Newhouse Pharmaceuticals SRL
Newhouse Pharmaceuticals reported total assets of €2.66m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026).
By total assets for 2025, Newhouse Pharmaceuticals ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Newhouse Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Newhouse Pharmaceuticals's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 13 Aug 2025
- Year ended 31 Dec 2023filed on 03 Jul 2024
- Year ended 31 Dec 2022filed on 25 Apr 2023
- Year ended 31 Dec 2021filed on 23 Aug 2022
Newhouse Pharmaceuticals's financial analysis
- Solvency48.7%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Newhouse Pharmaceuticals
Newhouse Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0687.802.947
- VAT number
- BE0687802947
- Peppol
- Registered · 0208:0687802947 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Jan 2018
- Registered office
- 8870 Izegem
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Newhouse Pharmaceuticals (SRL) has been based in Izegem since 2018, active in: activities of holding companies. For 2025, it reports a net profit of 142,769 € and equity of €1.30m; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Newhouse Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- JJ&Co Activities of holding companies Retie · balance sheet €2.66m
- Vemaphar Activities of holding companies Wevelgem · balance sheet €2.66m
- Sticaplast Activities of holding companies Ingelmunster · balance sheet €2.65m
- Holdco Wouter Activities of holding companies Tessenderlo-Ham · balance sheet €2.67m
- Vaditech Activities of holding companies Kalmthout · balance sheet €2.65m
- Brudo Activities of holding companies Veurne · balance sheet €2.65m
- G&D Invest Activities of holding companies Deerlijk · balance sheet €2.67m
- NBCE Activities of holding companies Antwerp · balance sheet €2.67m
Frequently asked questions about Newhouse Pharmaceuticals
What is the revenue of Newhouse Pharmaceuticals?
Newhouse Pharmaceuticals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Newhouse Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0687802947 for Newhouse Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0687.802.947.
Where is the registered office of Newhouse Pharmaceuticals?
According to the CBE register, the registered office of Newhouse Pharmaceuticals is in 8870 Izegem.
What is the equity of Newhouse Pharmaceuticals?
At the close of the 2025 financial year, the equity of Newhouse Pharmaceuticals amounts to 1,295,433 €, a solvency of 48.7% of total assets.
Who manages Newhouse Pharmaceuticals?
The register lists 1 active mandates at Newhouse Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Newhouse Pharmaceuticals within its sector?
By total assets for 2025, Newhouse Pharmaceuticals ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of Newhouse Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →